glp 1 agonist 종류 당뇨 주사 치료제의 모든 것, 약 소개와 사용법까지: ② GLP-1 수용체 효능제 : 네이버 블로그 약 이야기] 당뇨약이 비만약으로? 유행처럼

Description

How GLP-1 Drugs Differ Although they share a receptor target, GLP-1 medications differ in several clinically meaningful ways

Thus, other drug delivery strategies were used to develop longer-acting GLP-1 RAs, as described below

No clear increase in abnormal fetal growth

Tirzepatide-based evidence from the SURPASS (Researching Tirzepatide in Patients with Type 2 Diabetes for Glycemic Control and Weight Management) trials (SURPASS-1 NCT03954834 and SURPASS-5 NCT04039503) demonstrated dose-dependent, significant weight loss over 40 weeks compared with placebo, along with reductions in BMI and waist circumference [62, 63]

Since these formulations are regulated differently from name brands, there is often inconsistency in how they are assembled, labeled, and dosed, making it challenging for doctors to understand exactly what their patients are taking and how it might affect them